NCT01881789 Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT01879319 Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen Status COMPLETED Phase PHASE3
NCT01875991 Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept Status COMPLETED Phase PHASE4
NCT01869686 Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous Dose Status COMPLETED Phase PHASE1
NCT01868997 Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease Status COMPLETED Phase PHASE2
NCT01856881 Multiple Ascending Dose Study in Subjects With Type 2 Diabetes Status TERMINATED Phase PHASE1
NCT01854918 Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia Status COMPLETED Phase PHASE3
NCT01849497 Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen Status COMPLETED Phase PHASE3
NCT01833754 Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis Status COMPLETED Phase PHASE1
NCT01832727 Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT01825785 A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785) Status COMPLETED Phase PHASE1
NCT01824342 Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer Status COMPLETED Phase PHASE3
NCT01818752 Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01814501 Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab Status COMPLETED Phase PHASE2
NCT01813721 Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy. Status COMPLETED Phase N/A
NCT01813422 GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound Status COMPLETED Phase PHASE3
NCT01796301 An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women Status COMPLETED Phase PHASE3
NCT01792102 Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple Myeloma Status UNKNOWN Phase PHASE1/PHASE2